Herbal Drugs: Ethnomedicine to Modern Medicine

Herbal Drugs

K.G. Ramawat (Ed.) 2009 Considerable progress has been made in our healthcare system, in particular with respect to sensitive diagnostic tools, reagents and very effective and precise drugs. On the other hand, high-throughput screening technology can screen vast numbers of compounds against an array of targets in a very short time, and leads thus obtained can be further explored.

Continue reading →

Handbook of Stability Testing in Pharmaceutical Development

Handbook of Stability Testing in Pharmaceutical Development-1

Kim Huynh-Ba Editor 2009 Regulations, Methodologies, and Best Practices In my professional career as a pharmaceutical scientist, I have been involved with several aspects of the drug development process from pre-IND to commercialization and, somehow, I usually found myself coming back to a stability-related issue. The stability area seemed to draw my utmost interest because in my day-to-day […]

Continue reading →

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response-1

Edited by Federico Innocenti 2009 Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response provides the most comprehensive body of knowledge available on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. As a consequence of the intrinsic chromosomal and genetic instability of the tumor genome, it is generally believed that […]

Continue reading →

Drug-Related Problems in the Elderly

Drug-related problems in the elderly-1

Patrik Midl¨ov · Tommy Eriksson · Annika Kragh 2009 Drug-related problems in the elderly is intended to serve as a source of information and clinical support in geriatric pharmacotherapy for students as well as all health care professionals, e.g. physicians, nurses and pharmacists. Pharmacotherapy is of great importance to all mankind. Drugs are however powerful and must be […]

Continue reading →

Drug Resistance in Cancer Cells

Drug Resistance in Cancer Cells-1

Kapil Mehta · Zahid H. Siddik Editors 2009 It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosis and 565,650 individuals would die of cancer (Jemal et al. 2008). Since the vast majority of patients dying of cancer will have had anticancer therapy, both conventional chemotherapy and novel targeted therapy, it can be concluded […]

Continue reading →

Dictionary of Weighing Terms

Dictionary of Weighing Terms-1

Roland Nater · Arthur Reichmuth · Roman Schwartz Michael Borys · Panagiotis Zervos 2009 A Guide to the Terminology of Weighing This Dictionary of Weighing Terms is a comprehensive practical guide to the terminology of weighing for all users of weighing instruments in industry and science. It explains more than 1000 terms of weighing technology and related areas; […]

Continue reading →

Dendritic Cells in Cancer

Dendritic Cells in Cancer-1

Michael R. Shurin l Russell D. Salter Editors 2009 The role of dendritic cells in the immune system has been the subject of intense study for the past two decades, and it is now beyond question that these cells play a critical role in determining all aspects of the immune response, including its kinetics, magnitude, direction and character. […]

Continue reading →

Counteraction to Chemical in East European Countries and Biological Terrorism

Counteraction to Chemical and Biological Terrorism in East European Countries-1

Edited by C. Dishovsky A. Pivovarov 2009 The terrorist act with sarin gas in the Tokyo underground and the case with the spread of anthrax spores through the U.S. postal system stimulated the development of organization of fight against terrorism on a national and global level. The goal of this workshop was assessment of scientific concepts and practical […]

Continue reading →

CNS Cancer

CNS Cancer-1

Erwin G. Van Meir Editor 2009 Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches These are exciting times in neuro-oncology. By the time this book is published I will have worked in this field for 20 years, giving me enough perspective to contemplate significant changes during these two decades. In 1989 little was known about brain tumors and […]

Continue reading →